Atlas Trials

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

Clinical trial NCT01475721 · COMPLETED

Trial details

NCT number
NCT01475721
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Asthma
Start date
2011-11-18
Primary completion
2015-06-23
Enrollment
11751

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.